Li X - Search Results

1

Disruption of enhancer-driven S100A14 expression promotes esophageal carcinogenesis.

Li X, Ding F, Wang L, Chen H, Liu Z. Li X, et al. Cancer Lett. 2022 Oct 1;545:215833. doi: 10.1016/j.canlet.2022.215833. Epub 2022 Jul 30. Cancer Lett. 2022. PMID: 35917972

2

High expression of S100P is associated with unfavorable prognosis and tumor progression in patients with epithelial ovarian cancer.

Wang X, Tian T, Li X, Zhao M, Lou Y, Qian J, Liu Z, Chen H, Cui Z. Wang X, et al. Among authors: li x. Am J Cancer Res. 2015 Jul 15;5(8):2409-21. eCollection 2015. Am J Cancer Res. 2015. PMID: 26396916 Free PMC article.

3

MicroRNA-17/20a impedes migration and invasion via TGF-β/ITGB6 pathway in esophageal squamous cell carcinoma.

Jing C, Ma G, Li X, Wu X, Huang F, Liu K, Liu Z. Jing C, et al. Among authors: li x. Am J Cancer Res. 2016 Jul 1;6(7):1549-62. eCollection 2016. Am J Cancer Res. 2016. PMID: 27508097 Free PMC article.

4

MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer.

Zhan Y, Li X, Liang X, Li L, Cao B, Wang B, Ma J, Ding F, Wang X, Pang D, Liu Z. Zhan Y, et al. Among authors: li x, li l. Oncotarget. 2017 Jan 17;8(3):4629-4641. doi: 10.18632/oncotarget.13542. Oncotarget. 2017. PMID: 27894095 Free PMC article.

5

Integrin α6 promotes esophageal cancer metastasis and is targeted by miR-92b.

Ma G, Jing C, Huang F, Li X, Cao X, Liu Z. Ma G, et al. Among authors: li x. Oncotarget. 2017 Jan 24;8(4):6681-6690. doi: 10.18632/oncotarget.14259. Oncotarget. 2017. PMID: 28036265 Free PMC article.

6

S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition.

Tian T, Li X, Hua Z, Ma J, Wu X, Liu Z, Chen H, Cui Z. Tian T, et al. Among authors: li x. Oncotarget. 2017 Apr 11;8(15):24964-24977. doi: 10.18632/oncotarget.15329. Oncotarget. 2017. PMID: 28212564 Free PMC article.

7

S100A1 promotes cell proliferation and migration and is associated with lymph node metastasis in ovarian cancer.

Tian T, Li X, Hua Z, Ma J, Liu Z, Chen H, Cui Z. Tian T, et al. Among authors: li x. Discov Med. 2017 Apr;23(127):235-245. Discov Med. 2017. PMID: 28595036 Free article. Clinical Trial.

8

Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.

Ding F, Wang D, Li XK, Yang L, Liu HY, Cui W, Liu ZH, Che YQ. Ding F, et al. Thorac Cancer. 2018 Jul;9(7):827-835. doi: 10.1111/1759-7714.12654. Epub 2018 May 7. Thorac Cancer. 2018. PMID: 29733545 Free PMC article.

9

USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.

Wang L, Chen T, Li X, Yan W, Lou Y, Liu Z, Chen H, Cui Z. Wang L, et al. Among authors: li x. Int J Oncol. 2019 Jul;55(1):277-288. doi: 10.3892/ijo.2019.4818. Epub 2019 May 29. Int J Oncol. 2019. PMID: 31180526

10

S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.

Wang L, Yan W, Li X, Liu Z, Tian T, Chen T, Zou L, Cui Z. Wang L, et al. Among authors: li x. J Ovarian Res. 2019 Nov 18;12(1):113. doi: 10.1186/s13048-019-0592-3. J Ovarian Res. 2019. PMID: 31739800 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181,333 results

Search Page

Filters